One pill for all: new hope for children with HIV in africa
Disease control
Completed
This study tested a new dose of three proven HIV medicines (dolutegravir, emtricitabine, and tenofovir alafenamide) in children under 10 years old in Africa. The goal was to find the right dose to create a single, easy-to-take tablet that works for all children, just like adults.…
Phase: PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC